PG

Procter & Gamble Company
D

PG

Arincen73/100B

Procter & Gamble Company return on equity (ROE)

Procter & Gamble Company's return on equity is 29.26%: net income of 16.12B USD over the last twelve months on shareholders' equity of 55.10B USD.

Today
29.26%
Average, 5 years
30.96%
Low, 5 years
27.79%
High, 5 years
33.15%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 16.12B ÷ 55.10B = 29.26%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

Why is Procter & Gamble Company's return on equity so high?

Net margin
18.4%
profit on each dollar of sales
Asset turnover
0.69×
sales on each dollar of assets
Equity multiplier
2.33×
assets on each dollar of equity
Return on equity
29.5%
FY2026
  • FY202618.4% × 0.69 × 2.33 = 29.5%
  • FY202519.0% × 0.67 × 2.41 = 30.7%
  • FY202417.7% × 0.69 × 2.43 = 29.6%
  • FY202317.9% × 0.68 × 2.58 = 31.3%
  • FY202218.4% × 0.68 × 2.52 = 31.6%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today29.26%16.12B55.10B
FY202630 Jun 202629.73%16.14B54.31B
FY202530 Jun 202530.89%16.07B52.01B
FY202430 Jun 202429.78%14.97B50.29B
FY202330 Jun 202331.51%14.74B46.78B
FY202230 Jun 202231.75%14.79B46.59B
FY202130 Jun 202130.95%14.35B46.38B
FY202030 Jun 202028.17%13.10B46.52B
FY201930 Jun 20198.40%3.97B47.19B
FY201830 Jun 201818.86%9.86B52.29B
FY201730 Jun 201727.77%15.33B55.18B
FY201630 Jun 201618.49%10.60B57.34B
FY201530 Jun 201511.45%7.14B62.42B
FY201430 Jun 201417.03%11.79B69.21B
FY201330 Jun 201316.75%11.40B68.06B
FY201230 Jun 201217.19%10.90B63.44B
FY201130 Jun 201117.63%11.93B67.64B
FY201030 Jun 201020.84%12.74B61.12B
FY200930 Jun 200921.29%13.44B63.10B
FY200830 Jun 200817.38%12.08B69.49B
FY200730 Jun 200715.49%10.34B66.76B
FY200630 Jun 200613.80%8.68B62.91B
FY200530 Jun 200537.47%6.92B18.48B
FY200430 Jun 200437.51%6.48B17.28B
FY200330 Jun 200332.04%5.19B16.19B
FY200230 Jun 200231.75%4.35B13.71B
FY200130 Jun 200124.33%2.92B12.01B
FY200030 Jun 200028.83%3.54B12.29B
FY199930 Jun 199931.21%3.76B12.06B
FY199830 Jun 199830.89%3.78B12.24B
FY199730 Jun 199728.35%3.42B12.05B
FY199630 Jun 199625.99%3.05B11.72B
FY199530 Jun 199524.98%2.65B10.59B
FY199430 Jun 199425.03%2.21B8.83B
FY199330 Jun 19933.62%269.00M7.44B
FY199230 Jun 199220.64%1.87B9.07B
FY199130 Jun 199122.92%1.77B7.74B
FY199030 Jun 199021.31%1.60B7.52B
FY198930 Jun 198923.13%1.21B5.22B
FY198830 Jun 198816.10%1.02B6.34B
FY198730 Jun 19875.70%327.00M5.74B
FY198630 Jun 198612.43%709.00M5.70B

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Procter & Gamble Company's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.